10.1021/jo9025644
The research focuses on the development of a copper-catalyzed annulation reaction between 2-formylazoles and o-aminoiodoarenes, leading to the synthesis of substituted pyrrolo[1,2-a]quinoxalines and related heterocycles. This method provides a one-step route to these biologically active molecules, which are present in a growing number of pharmaceutical compounds. The reaction conditions were optimized using 2-iodoaniline and 2-formylpyrrole as starting materials, with the best results obtained using 1 equivalent of 2-formylpyrrole, 1.5 equivalents of 2-iodoaniline, 2 equivalents of K3PO4, 10 mol % CuI, 20 mol % sparteine, and NMP as the solvent at 130°C for 24 hours. The reaction was found to be effective for a variety of substituted aminoiodoarenes and formylazoles, including 2-formylimidazole, 2-formylbenzimidazole, and a 3-formylpyrazole. The synthesized products were analyzed using techniques such as high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and high-resolution mass spectrometry (HRMS) to confirm their structures and purities.
10.1021/jo400859s
The study presents a novel synthetic method for the production of 2-aryl-3-trifluoromethylquinolines, which are compounds of interest in pharmaceutical, agrochemical, and high-performance material sectors due to their significant roles. The researchers utilized a Hiyama cross-coupling reaction involving (E)-trimethyl(3,3,3-trifluoroprop-1-enyl)silane and 2-iodoaniline, facilitated by copper(II) fluoride and 2,2′-bipyridyl as a fluoride source and ligand, respectively. This reaction yielded (E)-2-(3,3,3-trifluoroprop-1-enyl)aniline without the need for amino group protection. Subsequently, an oxidative cyclization reaction with aryl aldehydes in the presence of a copper(I) salt catalyst, specifically [Cu(OTf)]2·C6H6, led to the formation of the target quinolines. The study's purpose was to develop an efficient synthetic protocol to access 3-trifluoromethylquinolines, which are challenging to synthesize using conventional methods, and to expand the library of such compounds for potential therapeutic applications.